Cytek Biosciences (CTKB) Interest Coverage Ratio (2020 - 2026)

Cytek Biosciences has reported Interest Coverage Ratio for 7 years, with the latest figure at 70.47 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio fell 36.94% year-over-year to 70.47; the trailing twelve-month figure through Mar 2026 stood at 98.59 (down 2245.48% YoY), and the FY2025 full-year result was 85.2, down 2274.9% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 70.47, down from 7.72 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 7.72 in Q4 2025, with the low at 70.47 in Q1 2026.
• Historically, Interest Coverage Ratio has averaged 19.84 across 5 years, with a median of 18.07 in 2023.
• Annual changes were most pronounced in 2023 — Interest Coverage Ratio plunged 1520.43% — and 2025, when it jumped 1633.09%.
• Cytek Biosciences' Interest Coverage Ratio stood at 0.12 in 2022, then tumbled by 384.38% to 0.35 in 2023, then tumbled by 44.74% to 0.5 in 2024, then jumped by 1633.09% to 7.72 in 2025, then tumbled by 1013.31% to 70.47 in 2026.
• The last three Interest Coverage Ratio figures came in at 70.47 (Q1 2026), 7.72 (Q4 2025), and 18.61 (Q3 2025), per Business Quant data.